妊娠期服用利扎曲普坦:截至2004年6月30日上市后的经验

妊娠期服用利扎曲普坦：截至2004年6月30日上市后的经
验
Fiore M.;Shields K.E.;Santanello N.;Goldberg M.R.;李一明
【期刊名称】《世界核心医学期刊文摘：神经病学分册》
【年(卷),期】2005(000)012
【摘要】Merck &Co., Inc. evaluates outcomes of the use of rizatriptan during pregnancy through a Pregnancy Registry in the United States (US) and spontaneous reports for pregnancies reported from sources outside the US. Review of the outcomes of 25 prospective pregnancy reports in the Pregnancy Registry and reports from other sources does not suggest that treatment with rizatriptan predisposes patients to spontaneous abortions or congenital anomalies. However, the number of reports is small. Healthcare providers in the United States are encouraged to report any prenatal exposure to rizatriptan by calling the Pregnancy Registry at +1 (800) 986 8999 or visiting the Registry’s website at
.
【总页数】2页(P27-28)
【作者】Fiore M.;Shields K.E.;Santanello N.;Goldberg M.R.;李一明
【作者单位】Clinical Risk Management and Safety Surveillance Merck Research Laboratories BLX-30 PO Box 4 West Point PA 19486 United States
【正文语种】中文
【中图分类】R173
【相关文献】
1.利扎曲普坦与舒马普坦治疗偏头痛的临床对照研究 [J], 张春驰;董艳娟;贺昕;何
跃
2.利扎曲普坦与舒马普坦治疗偏头痛的临床对照 [J], 吕春翔
3.丙二醇对利扎曲普坦普鲁兰多糖/麦芽糖糊精口腔速溶膜剂制剂学性质的影响 [J], Kiramat Ali Shah;高彬彬;李洁琼;崔京浩
4.5mg和10mg利扎曲普坦片与25mg和50mg舒马曲坦片对偏头痛疗效的比较研究 [J], Polis A.;Battisti W.P.;F. Skobieranda;黄卫东
5.利扎曲普坦和非利扎曲普坦常规药物治疗偏头痛的疗效比较:一项基于药店的研
究结果 [J], Cady R.;Martin V.;Adelman J.;X.H. Hu;李锐
因版权原因，仅展示原文概要，查看原文内容请购买。